798 related articles for article (PubMed ID: 33250386)
21. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette.
McEwan M; Azzopardi D; Gale N; Camacho OM; Hardie G; Fearon IM; Murphy J
Eur J Drug Metab Pharmacokinet; 2022 Mar; 47(2):211-221. PubMed ID: 34923602
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of Tobacco Exposure Decrease After Smokers Switch to an E-Cigarette or Nicotine Gum.
Round EK; Chen P; Taylor AK; Schmidt E
Nicotine Tob Res; 2019 Aug; 21(9):1239-1247. PubMed ID: 30202883
[TBL] [Abstract][Full Text] [Related]
23. Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.
Voos N; Smith D; Kaiser L; Mahoney MC; Bradizza CM; Kozlowski LT; Benowitz NL; O'Connor RJ; Goniewicz ML
Psychopharmacology (Berl); 2020 Feb; 237(2):491-502. PubMed ID: 31773209
[TBL] [Abstract][Full Text] [Related]
24. Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers.
Keyser BM; Hong KS; DeLuca P; Jin T; Jones BA; Nelson P; Schmidt E; Round EK
Sci Rep; 2023 Jun; 13(1):8894. PubMed ID: 37264061
[TBL] [Abstract][Full Text] [Related]
25. Room air constituent concentrations from use of electronic nicotine delivery systems and cigarettes using different ventilation conditions.
Oldham MJ; Sehgal A; Cohen G; Chen J; Evans B; Heraldez D
Sci Rep; 2021 Jan; 11(1):1736. PubMed ID: 33462299
[TBL] [Abstract][Full Text] [Related]
26. Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
D'Ruiz CD; Graff DW; Yan XS
BMC Public Health; 2015 Sep; 15():991. PubMed ID: 26424091
[TBL] [Abstract][Full Text] [Related]
27. Differences in nicotine intake and effects from electronic and combustible cigarettes among dual users.
St Helen G; Nardone N; Addo N; Dempsey D; Havel C; Jacob P; Benowitz NL
Addiction; 2020 Apr; 115(4):757-767. PubMed ID: 31691397
[TBL] [Abstract][Full Text] [Related]
28. Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.
Stein JS; Wilson AG; Koffarnus MN; Judd MC; Bickel WK
Psychopharmacology (Berl); 2017 Jan; 234(2):245-254. PubMed ID: 27730273
[TBL] [Abstract][Full Text] [Related]
29. Abuse liability of electronic cigarettes in men who are experienced electronic cigarette users.
Breland A; Maloney SF; Soule EK; Ramôa C; Barnes A; Lipato T; Eissenberg T
Exp Clin Psychopharmacol; 2020 Apr; 28(2):235-244. PubMed ID: 31259592
[TBL] [Abstract][Full Text] [Related]
30. Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers.
Brossard P; Weitkunat R; Poux V; Lama N; Haziza C; Picavet P; Baker G; Lüdicke F
Regul Toxicol Pharmacol; 2017 Oct; 89():193-199. PubMed ID: 28760390
[TBL] [Abstract][Full Text] [Related]
31. A Single-Dose, Crossover-Design Bioequivalence Study Comparing Two Nicotine Gum Formulations in Healthy Subjects.
Du D
Adv Ther; 2018 Aug; 35(8):1169-1180. PubMed ID: 30027479
[TBL] [Abstract][Full Text] [Related]
32. Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes.
St Helen G; Dempsey DA; Havel CM; Jacob P; Benowitz NL
Drug Alcohol Depend; 2017 Sep; 178():391-398. PubMed ID: 28704768
[TBL] [Abstract][Full Text] [Related]
33. A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes.
Ebajemito JK; McEwan M; Gale N; Camacho OM; Hardie G; Proctor CJ
Sci Rep; 2020 Nov; 10(1):19980. PubMed ID: 33235307
[TBL] [Abstract][Full Text] [Related]
34. A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes.
Chapman F; McDermott S; Rudd K; Taverner V; Stevenson M; Chaudhary N; Reichmann K; Thompson J; Nahde T; O'Connell G
Psychopharmacology (Berl); 2022 Sep; 239(9):2931-2943. PubMed ID: 35732751
[TBL] [Abstract][Full Text] [Related]
35. Human abuse liability assessment of e-cigarettes: Why, what and how?
Fearon IM
Drug Test Anal; 2023 Oct; 15(10):1211-1221. PubMed ID: 35302289
[TBL] [Abstract][Full Text] [Related]
36. Metabolomic Analysis Identified Reduced Levels of Xenobiotics, Oxidative Stress, and Improved Vitamin Metabolism in Smokers Switched to Vuse Electronic Nicotine Delivery System.
Liu G; Lin CJ; Yates CR; Prasad GL
Nicotine Tob Res; 2021 Jun; 23(7):1133-1142. PubMed ID: 33165576
[TBL] [Abstract][Full Text] [Related]
37. JUUL use and reasons for initiation among adult tobacco users.
Patel M; Cuccia A; Willett J; Zhou Y; Kierstead EC; Czaplicki L; Schillo B; Hair EC; Vallone D
Tob Control; 2019 Nov; 28(6):681-684. PubMed ID: 31217283
[TBL] [Abstract][Full Text] [Related]
38. The effect of potential electronic nicotine delivery system regulations on nicotine product selection.
Pesko MF; Kenkel DS; Wang H; Hughes JM
Addiction; 2016 Apr; 111(4):734-44. PubMed ID: 26639526
[TBL] [Abstract][Full Text] [Related]
39. Abuse liability of cigarettes with very low nicotine content in pregnant cigarette smokers.
Heil SH; Bergeria CL; Lee DC; Bunn JY; Harfmann RF; Hughes JR; Tetreault HJ; Higgins ST
Prev Med; 2020 Nov; 140():106227. PubMed ID: 32768512
[TBL] [Abstract][Full Text] [Related]
40. High-Nicotine Electronic Cigarette Products: Toxicity of JUUL Fluids and Aerosols Correlates Strongly with Nicotine and Some Flavor Chemical Concentrations.
Omaiye EE; McWhirter KJ; Luo W; Pankow JF; Talbot P
Chem Res Toxicol; 2019 Jun; 32(6):1058-1069. PubMed ID: 30896936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
